Navigation Links
Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
Date:6/25/2008

Award Recognizes Entrepreneurial Excellence in Emerging Category

LOS ANGELES, June 25 /PRNewswire/ -- Agensys, Inc. a biotechnology company, today announced that Dr. Donald Rice, Founder, President, & CEO, received the Ernst & Young Entrepreneur Of The Year(R) 2008 Award in the Emerging category in the Greater Los Angeles Area. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. Dr. Donald Rice was selected by an independent panel of judges, and the award was presented at a gala event at the Beverly Hilton Hotel on June 24, 2008.

"This award belongs to the entire Agensys team, a small group that built an integrated biotech company that has so far brought forward 5 novel products that will help many cancer patients in the future," said Dr. Rice. "Helping cancer sufferers will be the ultimate reward."

Agensys develops monoclonal antibodies to its own novel targets to treat a variety of human cancers. After 10 years as a private company, the entire Agensys team was acquired by Astellas Pharma, Inc., the second largest Japanese pharmaceutical company, in December, 2007. It operates today as a separate subsidiary of the parent, with Dr. Rice as President and CEO.

The Ernst & Young Entrepreneur Of The Year awards celebrate their 22nd anniversary this year. The program honors entrepreneurs who have demonstrated exceptionality in such areas as innovation, financial performance and personal commitment to their businesses and communities.

"Ernst & Young is pleased to honor outstanding business leaders such as Dr. Donald Rice," said Brian Ring, Ernst & Young Entrepreneur Of The Year Program Director for the Greater Los Angeles Area. "Winners of the Entrepreneur Of The Year award build leading businesses and contribute a great deal to the communities around them. Their success helps our area grow stronger."

As a Greater Los Angeles Area award w
'/>"/>

SOURCE Agensys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
2. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
3. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
4. Stereotaxis Appoints Senior Vice President, North America
5. Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors
6. Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
7. Orchid Cellmark Appoints Jeffrey S. Boschwitz as Vice President, North America Marketing & Sales
8. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
11. Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...nk of it as origami very high-tech origami. , Re...oped a technique for fabricating three-dimensional...films by coupling photolithography and a self-fold...he films, only a few microns thick, offer mechanic...ieces of the same material. , "This is a complete...
(Date:11/23/2009)...imensional carbon layer in which the carbon atoms ...honeycomb. Carbon nanotubes are rolled-up sheets o...m graphite. Graphene boasts some very special char...cellent thermal conductor, and reconciles such con...n addition, graphene is impermeable to gases, whic...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
... Amnis Corporation announced today the,release of ...ding the,Commercial release of a multilaser capabi...dramatically extending the depth of field well bey...ser upgrade provides the customer with the flexibi...05nm (violet) laser and a 658nm,(red) laser. These...
...., Aug. 23 Nektar,Therapeutics (Nasdaq: NKTR ) t...Senior Vice President and CFO. Harkness reports to...l serve as an integral member of the company,s,new...of healthcare and finance, Tim is a,critical addit... "He brings,significant experience in both financi...
...ia, Aug. 23 , Highlights -- Revenue increased 28...illion -- Excluding one-off items EBITDA increase...6 million -- Excluding one-off items NPAT increas....5 million from A$2.0 million -- Reported NPAT gr...r comparable period including one-off items -...
Other Biology Technology:Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 3Ellex FY2007 Year End Results 2Ellex FY2007 Year End Results 3
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)...oday named 12 new grant recipients for 2009. The a... work across a broad spectrum of lupus research. A...d potential to drive scientific discovery to ultim... of systemic lupus. , The 2009 grants go to both...nation and include interdisciplinary and highly pr...
(Date:11/24/2009)...in that may help gut bacteria bind to the gastroin...otic producers to identify strains that are likely...eed to interact with cells lining the gut to have ...s in the gut they are more likely to stick around ...alie Juge from the Institute of Food Research. IF...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2One Shot May Someday Replace Six for Rabies 58126 1One Shot May Someday Replace Six for Rabies 58126 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 1University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6
...available in French . , A novel x-ray technique... time scale never reached before has been develope...Scherrer Institute (PSI) in Switzerland. Results o...d of EPFL,s laboratory of Ultrafast Spectroscopy i... online December 11 in the journal Science . , T...
...a turtle,s first swim is the most critical of its ...ators to make it to the sea, the tiny voyager must...its bid for freedom. For youngsters hatching on th...gh: as many as 30% perish as they head for safe de...rough the waves cost the intrepid hatchlings? Curi...
...uma National Park, the last stronghold for the sav...ow hover at about 1,000 animals, down from an esti...ic weapons have decimated elephant populations pa...f the park., Civil unrest in has made conservatio...rds have been shot and killed in recent years. Ho...
Other Biology News:Molecules in the spotlight 2Cost of hatchling turtles' dash for freedom 2Missing: 2,000 elephants 2
...ulti-casting chamber is used for handcasting and v...ndcast (8.3 x 7.3 cm) or precast (8.6 x 6.8 cm) ge...udes an electrophoresis tank with built-in cooling...rculator (not included), lid with power cables, 6 ...
Protease Inhibitor Cocktail Set I from Calbiochem
...gnificantly increase the shelf life of diluted per...at room temperature storage conditions in addition...0.2 micron filtration, and contains no mercury or ... levels of activity for both the enzyme and the an...
NucleoSpin Extract II from MACHEREY-NAGEL
Biology Products: